Home > Business > Distribution > Distribution abroad

Distribution abroad

The distribution abroad is carried out by the local structures and partners abroad:

Sopharma Ukraine Ltd
Geroev Stalingrada avenue 53B
04213, Kiev, Ukraine
Tel./ fax: +380 44 351 13 69/70/71
e-mail: office@sopharma.net.ua

Representative office of Sopharma AD in Ukraine
Business Centre "Forum Park Plaza"
9 Moskovskij prospect,
4-203 office, 04073, Kiev, Ukraine
Tel./ fax: +380 44 351 13 69/70/71
e-mail: office@sopharma.net.ua

Representative office of Sopharma AD in Azerbaijan
Baku 1078, Azerbaijan
19A, Jafar Handan str., ap. 8
Tel.: (+994 12) 449-83-02
Tel./fax: (+994 12) 449-87-55
e-mail: office@sopharma.az

Representative office of Sopharma AD in Armenia Armenia,
Yerevan 3,
Zakian str., ap. 114
Tel.: +374 10 51 22 21
Tel.: +374 10 51 22 23
e-mail: mshatvoryan@gmail.com

TOO „Sopharma Kazakhstan”
050036, Almaty, Mamyr-4 Region №190
Tel.: +7 727 380 0103
Fax.: +7 727 381 6386
e-mail: office@sopharma.kz

SIA BRIZ

General information


The main directions of economic activity are:

  1. Distribution of medicines and dietary supplements in the wholesale and retail segment;
  2. Distribution of cosmetics and perfumery products in the wholesale and retail segment;
  3. Registration of medicines in Latvia, Lithuania, Estonia, Belarus, Bulgaria
  4. Launch of the medicines produced in third countries to the European Union;
  5. Marketing support of the products on the mentioned markets.
  6. Production.

The company is constantly evolving, having certificates of GMP, GDP, the license to import medicines produced in third countries into the EU, as well as psychotropic license. In 2015, the company successfully passed the next commission on the re-certification of GMP and GDP. The company's mission is to meet the needs of customers in the natural, effective and modern medicines and cosmetics, dietary supplements, that improve health and quality of life. Using the resources and capabilities, we will promptly provide our customers with quality medicines and essential goods. The main objective of the company is to increase the portfolio of SIA "BRIZ" products and Sopharma AD products on the markets of Latvia, Lithuania, Estonia and Belarus. Besides representative, sales and marketing services, the company successfully provides services on pharmacovigilance for its customers.

Main financial indicators

Indicators20152014Change%
BGN '000
Sales revenues 33,683 33,265
Operating profit 1,042 1,146
Net profit 887 661
 31.12.201531.12.2014
BGN '000
Non-current assets 36,400 35,070
Current assets 33,367 34,049
Owners' equity 33,878 37,181
Non-current liabilities 692 700
Current liabilities 31,197 31,238

Ratios20152014
Operating profit/ Sales revenue 3.1% 3.4%
Net profit/ Sales revenue 2.6% 2%
Borrowed capital/ Equity 0.94